In Reply: Neoadjuvant Versus Adjuvant Chemotherapy for Resectable Metastatic Colon Cancer in Non-academic and Academic Programs.
I-Hsuan SuJennifer L LundCharles E GaberHanna K SanoffPaula D StrassleEmilie D DuchesneauPublished in: The oncologist (2023)